- Home
- VRAX vs REBN Comparison
VRAX vs REBN Comparison
Compare VRAX & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- REBN
- Stock Information
- Founded
- VRAX 2013
- REBN 2015
- Country
- VRAX United Kingdom
- REBN United States
- Employees
- VRAX N/A
- REBN N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- REBN Restaurants
- Sector
- VRAX Health Care
- REBN Consumer Discretionary
- Exchange
- VRAX Nasdaq
- REBN Nasdaq
- Market Cap
- VRAX 4.4M
- REBN 15.3M
- IPO Year
- VRAX 2022
- REBN 2022
- Fundamental
- Price
- VRAX $0.61
- REBN $2.67
- Analyst Decision
- VRAX Strong Buy
- REBN
- Analyst Count
- VRAX 1
- REBN 0
- Target Price
- VRAX $3.00
- REBN N/A
- AVG Volume (30 Days)
- VRAX 1.6M
- REBN 89.9K
- Earning Date
- VRAX 01-01-0001
- REBN 08-14-2025
- Dividend Yield
- VRAX N/A
- REBN N/A
- EPS Growth
- VRAX N/A
- REBN N/A
- EPS
- VRAX N/A
- REBN N/A
- Revenue
- VRAX $6,331.00
- REBN $6,565,623.00
- Revenue This Year
- VRAX $217,274.83
- REBN $335.98
- Revenue Next Year
- VRAX N/A
- REBN N/A
- P/E Ratio
- VRAX N/A
- REBN N/A
- Revenue Growth
- VRAX N/A
- REBN 14.03
- 52 Week Low
- VRAX $0.52
- REBN $1.03
- 52 Week High
- VRAX $3.62
- REBN $8.30
- Technical
- Relative Strength Index (RSI)
- VRAX 40.99
- REBN 50.93
- Support Level
- VRAX $0.54
- REBN $2.33
- Resistance Level
- VRAX $0.70
- REBN $2.70
- Average True Range (ATR)
- VRAX 0.06
- REBN 0.18
- MACD
- VRAX 0.01
- REBN 0.01
- Stochastic Oscillator
- VRAX 50.56
- REBN 60.91
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.